HMGB1 and ovarian cancer: To determine whether the HMGB1 expression was associated with patient survival, we stained a primary (Nottingham) cohort comprised of 194 ovarian cancer cases using immunohistochemistry with a rabbit monoclonal antibody specific for endogenous HMGB1.